indol

Embed Size (px)

DESCRIPTION

.

Citation preview

  • Synevohttp://www.synevo.ro

    Acid5hidroxiindolaceticPostedBySynevoOnaugust19,2009@4:34pmInMarkeritumorali|NoComments

    Informatiigeneralesirecomandaripentrudeterminareaacidului5hidroxiindolaceticurinar

    Acidul5hidroxiindolacetic(5HIIA)esteprincipalulmetaboliturinaralserotoninei,oaminabiologicactivaprodusainmodnormaldeceluleleargentafinedintractulgastrointestinal.Functiaacestorceluleconstainreglareacontractieimusculaturiinetedesiaperistaltismuluiintestinal,serotoninafiindinesentaunhormonvasoconstrictor.

    Determinarea5HIIAinurinaareutilitateindiagnosticultumorilorcarcinoide,caracterizateprintrocresteresemnificativaaacestuimetaboliturinar2.

    Tumorilecarcinoidefacpartedincategoriatumorilorneuroendocrine,avandoincidentascazutainpopulatiesioevolutielenta.Celemaifrecventegrupedevarstaafectatesunt:1525anisi6575ani.Tumorilesedezvoltacelmaiadeseasporadic,insaexistacativafactoriderisc:

    neoplaziaendocrinamultipladetip1(MEN1)asociatain10%dincazuricutumorineuroendocrinepulmonare,aletimusuluisistomacului

    sindromulvonHippelLindauasociatin15%dincazuricutumoripancreaticedeorigineneuroendocrina

    neurofibromatozadetipI(boalavonRecklinghausen)asociataincazurirarecutumoricarcinoidealeduodenului.

    Dinpunctdevederehistologic,tumorilecarcinoidesedezvoltadinceluleleenterocromafine(Kulchitsky)infunctiedeloculdeorigineatumoriiseclasificain:

  • tumoriderivatedinparteacranialaatubuluidigestivprimitiv:pancreatice,duodenale,gastrice,bronsice

    tumoriderivatedinparteamedialaatubuluidigestivprimitiv:jejunale,ilealesilanivelulapendicelui

    tumoriderivatedinparteacaudalaatubuluidigestivprimitiv:incolonulascendentsirect

    tumoricualteorigini:timice,ovariene,renale,mamare.

    Tabloulclinicesteadeseanespecific,iarinunelecazuritumorilesuntdepistateintamplatorcuocaziainterventiilorchirurgicalepentruapendicitasiocluzieintestinala.Doar10%dintrepacientiprezintasimptomesisemneclinicetipicesindromuluicarcinoid:flushing,diaree,dureriabdominale,hepatomegalie(metastazelehepaticesuntfrecvente),bronhospasmsiafectarecardiaca(fibrozavalvulara).Simptomelesuntindusedeeliberareadesubstanteneuroendocrine1.Alaturideserotonina,tumorilecarcinoidemaipotdeterminaoexcretiecrescutadetriptofan,5hidroxitriptofansihistamina.Ocazionalsuntsecretatisialticompusicumarfi:ACTH,gastrina[1],insulina,polipeptidintestinalvasoactiv(VIP)sicalcitonina[2].

    Productiadeserotoninasimetabolismulacestuihormonsuntinfluentatedetesutuldeorigineatumorii.Astfel,tumorilederivatedinparteamedialaatubuluidigestivprimitiv,cumarficeleileale,continsielibereazadeobiceicantitatimarideserotonina,careinsanusereflectaintrocrestereproportionalaaeliminariide5HIIAinurina,deoareceaceastaestemetabolizataintrocantitateredusa.Pedealtaparte,tumorilebronsice,pancreatice,duodenalesaubiliareproduccantitatimarideserotoninacareesteoxidataintratumoralin5HIIAsiinacestecazuriexcretiametabolituluiestemultmaimaredecatceasuspectataclinic.Carcinoidelerectalerareoriproduccantitaticrescutedeserotoninasau5HIIA.

    Existaocorelatieslabaintrenivelulde5HIIAurinarsiseveritateaclinicaasindromuluicarcinoid.Studiirecenteconfirmainsautilitateasacafactordeprognosticalbolii5.

    Pregatirepacientsevaevitaconsumuldebanane,ananas,prune,kiwi,pepenegalben,nuci,cacao,rosii,avocado,vinetecu72oreinaintearecoltarii(deoareceacestealimentecontinserotonina).Deasemeneaestedepreferatsaseintrerupamedicatiacarepoateproduceinterferentecu3zileinaintearecoltarii:acetaminofen,

  • salicilati,fenacetin,naproxen,clorpromazina,imipraminasiinhibitoridemonoaminoxidaza24.

    Specimenrecoltaturinadin24ore:laora7dimineatapacientulurineazasinuretineaceastaurinaapoicolecteazaintrunvascuratde23litritoateemisiuniledeurinapanalaora7dimineatainziuaurmatoare,inclusivomogenizeaza(prinagitare)urinarecoltatamasoaraintreagacantitateretineaprox.10mL,inpahardeplasticdeunicafolosintapentruurina.Probasetinela28Cintimpulcolectariisiulterior,panaselucreazaefectiv4.

    Recipientderecoltarevasde23litrisipahardeplasticdeunicafolosintapentruurina,pecaresenoteazacantitateatotaladeurinadin24deore4.

    Cantitaterecoltata10mL4.

    Cauzederespingereaprobeispecimencarenuafostpastratla28C4.

    Prelucrarenecesaraduparecoltareestedepreferatsaselucrezeimediatdacacestlucrunuesteposibil,probasepoatestocala28C,dupaceinprealabilseadaugaacidclorhidricconcentratpanaseajungelaunpH25mg/24oreindicatumoricarcinoidemari,adeseacumetastaze2.Obtinereaunorvaloridegranitasauusorcrescuteimpunerepetarearecoltariiprobei,curespectareastrictaadieteirecomandatesievitareamedicamentelorcarepotproduceinterferente.Atuncicandunpacientcususpiciuneclinicamaredesindrom

  • carcinoidprezintavaloride5HIIAnormalesaudegranita,trebuieluateinconsiderare2posibilitati:fietumoraproducecantitatimarideserotoninacarenuestemetabolizatasiinacestcazdozareaserotonineisericevaajutalastabilireadiagnosticului,fiesecretiade5HIIAesteintermitenta,situatieincaretrebuierecoltatemaimulteprobedeurinapentruapuneinevidentaanomalia5.

    Cresteriusoarede5HIIAsemaipotintalniinspruenontropical.Deasemeneasepotinregistravaloricrescutesilapacientiicumalabsorbtienetratata,careprezintaniveluriridicatedemetabolitiurinariaitriptofanului,cumarficeicuboalaceliaca,boalaWhipplesifibrozachistica5.

    Valoriscazutede5HIIAsuntintalnitelapacientiicuinsuficientarenala,rezectiedeintestinsubtire,fenilcetonurie,boalaHartnup,mastocitoza2.

    Limitesiinterferente

    5HIIApoateprezentavalorinormalelapacientiicutumoricarcinoidenonmetastaticesichiarsilaopartedinceicusindromcarcinoid,maialesdacadiareeaesteabsenta.

    Uniipacienticusindromcarcinoidexcretaaciziindolicinonhidroxilaticarenusuntmasuratiladeterminarea5HIIA5.

    Prindozareaserotonineisericesepotdiagnosticatumoricarcinoidelacaredeterminarea5HIIAadatrezultate[3]

    negative25.

    Medicamente

    Cresteri:acetaminofen,clordiazepoxid,cisplatin,clorpromazina,diazepam,efedrina,fenobarbital,fentolamina,flurazepam,fluorouracil,guaifenesin,melfalan,methocarbamol,naproxen,sulfasalazina,rezerpina3.

    Scaderi:aspirina,clorpromazin,corticotropin,imipramina,inhibitorideMAO,interferonalfa2a,izoniazida,levodopa,metildopa,octreotid,promazina,streptozocin3.

  • Bibliografie

    1.ARUPLaboratories.PhysicianGuide:CarcinoidTumors.www.aruplab.com.2010.RefType:InternetCommunication.

    2.FrancesFischbach.UrineTesting.InAManualofLaboratoryandDiagnosticTest.LippincottWilliams&Wilkins,USA,8Ed.,2009,262264.

    3.FrancesFischbach.EffectsoftheMostCommonlyUsedDrugsonFrequentlyOrderedLaboratoryTests.InAManualofLaboratoryandDiagnosticTests.LippincottWilliams&Wilkins,USA,8Ed.,2009,1243.

    4.LaboratorSynevo.Referinelespecificetehnologieidelucruutilizate.2014.RefType:Catalog.

    5.LaboratoryCorporationofAmerica.DirectoryofServicesandInterpretiveGuide.5HydroxyindoleaceticAcid(HIAA),

    Quantitative,24HourUrine.www.labcorp.com[4]2014.RefType:InternetCommunication.

    ArticleprintedfromSynevo:http://www.synevo.ro

    URLtoarticle:http://www.synevo.ro/acid5hidroxiindolacetic/

    URLsinthispost:

    [1]gastrina:http://www.synevo.ro/gastrina/[2]calcitonina:http://www.synevo.ro/calcitonina/[3]rezultate:http://www.synevo.ro/spitale/rezultate/[4]www.labcorp.com:http://www.labcorp.com/

  • Copyright2009Synevo.Toatedrepturilerezervate.